Massive review of 2,500 patient records to map Real-World hives treatment
NCT ID NCT07450170
Summary
This study aims to understand how doctors in China actually prescribe the drug omalizumab for adults with chronic hives (urticaria) in everyday practice. It will review the health records of about 2,500 patients to see what doses are used, how long treatment lasts, and what other medications patients take. The goal is to gather knowledge about real-world treatment patterns, not to test a new cure or treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC URTICARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Conditions
Explore the condition pages connected to this study.